Cargando…

Prognostic Factors and a New Prognostic Index Model for Children and Adolescents with Hodgkin’s Lymphoma Who Underwent Autologous Hematopoietic Stem Cell Transplantation: A Multicenter Study of the Turkish Pediatric Bone Marrow Transplantation Study Group

OBJECTIVE: The prognostic factors and a new childhood prognostic index after autologous hematopoietic stem cell transplantation (AHSCT) in patients with relapsed/refractory Hodgkin’s lymphoma (HL) were evaluated. MATERIALS AND METHODS: The prognostic factors of 61 patients who underwent AHSCT betwee...

Descripción completa

Detalles Bibliográficos
Autores principales: Kesik, Vural, Ataş, Erman, Karakükcü, Musa, Aksoylar, Serap, Erbey, Fatih, Taçyıldız, Nurdan, Küpesiz, Alphan, Öniz, Haldun, Ünal, Ekrem, Kansoy, Savaş, Öztürk, Gülyüz, Elli, Murat, Kaya, Zühre, Ünal, Emel, Hazar, Volkan, Yılmaz Bengoa, Şebnem, Karasu, Gülsün, Atay, Didem, Dağdemir, Ayhan, Ören, Hale, Koçak, Ülker, Yeşilipek, M. Akif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5204179/
https://www.ncbi.nlm.nih.gov/pubmed/27094103
http://dx.doi.org/10.4274/tjh.2015.0280
_version_ 1782489854504861696
author Kesik, Vural
Ataş, Erman
Karakükcü, Musa
Aksoylar, Serap
Erbey, Fatih
Taçyıldız, Nurdan
Küpesiz, Alphan
Öniz, Haldun
Ünal, Ekrem
Kansoy, Savaş
Öztürk, Gülyüz
Elli, Murat
Kaya, Zühre
Ünal, Emel
Hazar, Volkan
Yılmaz Bengoa, Şebnem
Karasu, Gülsün
Atay, Didem
Dağdemir, Ayhan
Ören, Hale
Koçak, Ülker
Yeşilipek, M. Akif
author_facet Kesik, Vural
Ataş, Erman
Karakükcü, Musa
Aksoylar, Serap
Erbey, Fatih
Taçyıldız, Nurdan
Küpesiz, Alphan
Öniz, Haldun
Ünal, Ekrem
Kansoy, Savaş
Öztürk, Gülyüz
Elli, Murat
Kaya, Zühre
Ünal, Emel
Hazar, Volkan
Yılmaz Bengoa, Şebnem
Karasu, Gülsün
Atay, Didem
Dağdemir, Ayhan
Ören, Hale
Koçak, Ülker
Yeşilipek, M. Akif
author_sort Kesik, Vural
collection PubMed
description OBJECTIVE: The prognostic factors and a new childhood prognostic index after autologous hematopoietic stem cell transplantation (AHSCT) in patients with relapsed/refractory Hodgkin’s lymphoma (HL) were evaluated. MATERIALS AND METHODS: The prognostic factors of 61 patients who underwent AHSCT between January 1990 and December 2014 were evaluated. In addition, the Age-Adjusted International Prognostic Index and the Childhood International Prognostic Index (CIPI) were evaluated for their impact on prognosis. RESULTS: The median age of the 61 patients was 14.8 years (minimum-maximum: 5-20 years) at the time of AHSCT. There were single relapses in 28 patients, ≥2 relapses in eight patients, and refractory disease in 25 patients. The chemosensitivity/chemorefractory ratio was 36/25. No pretransplant radiotherapy, no remission at the time of transplantation, posttransplant white blood cell count over 10x10(3)/µL, posttransplant positron emission tomography positivity at day 100, and serum albumin of <2.5 g/dL at diagnosis were correlated with progression-free survival. No remission at the time of transplantation, bone marrow positivity at diagnosis, and relapse after AHSCT were significant parameters for overall survival. CONCLUSION: The major factors affecting the progression-free and overall survival were clearly demonstrated. A CIPI that uses a lactate dehydrogenase level of 500 IU/L worked well for estimating the prognosis. We recommend AHSCT at first complete remission for relapsed cases, and it should also be taken into consideration for patients with high prognostic scores at diagnosis.
format Online
Article
Text
id pubmed-5204179
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-52041792017-01-06 Prognostic Factors and a New Prognostic Index Model for Children and Adolescents with Hodgkin’s Lymphoma Who Underwent Autologous Hematopoietic Stem Cell Transplantation: A Multicenter Study of the Turkish Pediatric Bone Marrow Transplantation Study Group Kesik, Vural Ataş, Erman Karakükcü, Musa Aksoylar, Serap Erbey, Fatih Taçyıldız, Nurdan Küpesiz, Alphan Öniz, Haldun Ünal, Ekrem Kansoy, Savaş Öztürk, Gülyüz Elli, Murat Kaya, Zühre Ünal, Emel Hazar, Volkan Yılmaz Bengoa, Şebnem Karasu, Gülsün Atay, Didem Dağdemir, Ayhan Ören, Hale Koçak, Ülker Yeşilipek, M. Akif Turk J Haematol Research Article OBJECTIVE: The prognostic factors and a new childhood prognostic index after autologous hematopoietic stem cell transplantation (AHSCT) in patients with relapsed/refractory Hodgkin’s lymphoma (HL) were evaluated. MATERIALS AND METHODS: The prognostic factors of 61 patients who underwent AHSCT between January 1990 and December 2014 were evaluated. In addition, the Age-Adjusted International Prognostic Index and the Childhood International Prognostic Index (CIPI) were evaluated for their impact on prognosis. RESULTS: The median age of the 61 patients was 14.8 years (minimum-maximum: 5-20 years) at the time of AHSCT. There were single relapses in 28 patients, ≥2 relapses in eight patients, and refractory disease in 25 patients. The chemosensitivity/chemorefractory ratio was 36/25. No pretransplant radiotherapy, no remission at the time of transplantation, posttransplant white blood cell count over 10x10(3)/µL, posttransplant positron emission tomography positivity at day 100, and serum albumin of <2.5 g/dL at diagnosis were correlated with progression-free survival. No remission at the time of transplantation, bone marrow positivity at diagnosis, and relapse after AHSCT were significant parameters for overall survival. CONCLUSION: The major factors affecting the progression-free and overall survival were clearly demonstrated. A CIPI that uses a lactate dehydrogenase level of 500 IU/L worked well for estimating the prognosis. We recommend AHSCT at first complete remission for relapsed cases, and it should also be taken into consideration for patients with high prognostic scores at diagnosis. Galenos Publishing 2016-12 2016-12-01 /pmc/articles/PMC5204179/ /pubmed/27094103 http://dx.doi.org/10.4274/tjh.2015.0280 Text en © Turkish Journal of Hematology, Published by Galenos Publishing. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kesik, Vural
Ataş, Erman
Karakükcü, Musa
Aksoylar, Serap
Erbey, Fatih
Taçyıldız, Nurdan
Küpesiz, Alphan
Öniz, Haldun
Ünal, Ekrem
Kansoy, Savaş
Öztürk, Gülyüz
Elli, Murat
Kaya, Zühre
Ünal, Emel
Hazar, Volkan
Yılmaz Bengoa, Şebnem
Karasu, Gülsün
Atay, Didem
Dağdemir, Ayhan
Ören, Hale
Koçak, Ülker
Yeşilipek, M. Akif
Prognostic Factors and a New Prognostic Index Model for Children and Adolescents with Hodgkin’s Lymphoma Who Underwent Autologous Hematopoietic Stem Cell Transplantation: A Multicenter Study of the Turkish Pediatric Bone Marrow Transplantation Study Group
title Prognostic Factors and a New Prognostic Index Model for Children and Adolescents with Hodgkin’s Lymphoma Who Underwent Autologous Hematopoietic Stem Cell Transplantation: A Multicenter Study of the Turkish Pediatric Bone Marrow Transplantation Study Group
title_full Prognostic Factors and a New Prognostic Index Model for Children and Adolescents with Hodgkin’s Lymphoma Who Underwent Autologous Hematopoietic Stem Cell Transplantation: A Multicenter Study of the Turkish Pediatric Bone Marrow Transplantation Study Group
title_fullStr Prognostic Factors and a New Prognostic Index Model for Children and Adolescents with Hodgkin’s Lymphoma Who Underwent Autologous Hematopoietic Stem Cell Transplantation: A Multicenter Study of the Turkish Pediatric Bone Marrow Transplantation Study Group
title_full_unstemmed Prognostic Factors and a New Prognostic Index Model for Children and Adolescents with Hodgkin’s Lymphoma Who Underwent Autologous Hematopoietic Stem Cell Transplantation: A Multicenter Study of the Turkish Pediatric Bone Marrow Transplantation Study Group
title_short Prognostic Factors and a New Prognostic Index Model for Children and Adolescents with Hodgkin’s Lymphoma Who Underwent Autologous Hematopoietic Stem Cell Transplantation: A Multicenter Study of the Turkish Pediatric Bone Marrow Transplantation Study Group
title_sort prognostic factors and a new prognostic index model for children and adolescents with hodgkin’s lymphoma who underwent autologous hematopoietic stem cell transplantation: a multicenter study of the turkish pediatric bone marrow transplantation study group
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5204179/
https://www.ncbi.nlm.nih.gov/pubmed/27094103
http://dx.doi.org/10.4274/tjh.2015.0280
work_keys_str_mv AT kesikvural prognosticfactorsandanewprognosticindexmodelforchildrenandadolescentswithhodgkinslymphomawhounderwentautologoushematopoieticstemcelltransplantationamulticenterstudyoftheturkishpediatricbonemarrowtransplantationstudygroup
AT ataserman prognosticfactorsandanewprognosticindexmodelforchildrenandadolescentswithhodgkinslymphomawhounderwentautologoushematopoieticstemcelltransplantationamulticenterstudyoftheturkishpediatricbonemarrowtransplantationstudygroup
AT karakukcumusa prognosticfactorsandanewprognosticindexmodelforchildrenandadolescentswithhodgkinslymphomawhounderwentautologoushematopoieticstemcelltransplantationamulticenterstudyoftheturkishpediatricbonemarrowtransplantationstudygroup
AT aksoylarserap prognosticfactorsandanewprognosticindexmodelforchildrenandadolescentswithhodgkinslymphomawhounderwentautologoushematopoieticstemcelltransplantationamulticenterstudyoftheturkishpediatricbonemarrowtransplantationstudygroup
AT erbeyfatih prognosticfactorsandanewprognosticindexmodelforchildrenandadolescentswithhodgkinslymphomawhounderwentautologoushematopoieticstemcelltransplantationamulticenterstudyoftheturkishpediatricbonemarrowtransplantationstudygroup
AT tacyıldıznurdan prognosticfactorsandanewprognosticindexmodelforchildrenandadolescentswithhodgkinslymphomawhounderwentautologoushematopoieticstemcelltransplantationamulticenterstudyoftheturkishpediatricbonemarrowtransplantationstudygroup
AT kupesizalphan prognosticfactorsandanewprognosticindexmodelforchildrenandadolescentswithhodgkinslymphomawhounderwentautologoushematopoieticstemcelltransplantationamulticenterstudyoftheturkishpediatricbonemarrowtransplantationstudygroup
AT onizhaldun prognosticfactorsandanewprognosticindexmodelforchildrenandadolescentswithhodgkinslymphomawhounderwentautologoushematopoieticstemcelltransplantationamulticenterstudyoftheturkishpediatricbonemarrowtransplantationstudygroup
AT unalekrem prognosticfactorsandanewprognosticindexmodelforchildrenandadolescentswithhodgkinslymphomawhounderwentautologoushematopoieticstemcelltransplantationamulticenterstudyoftheturkishpediatricbonemarrowtransplantationstudygroup
AT kansoysavas prognosticfactorsandanewprognosticindexmodelforchildrenandadolescentswithhodgkinslymphomawhounderwentautologoushematopoieticstemcelltransplantationamulticenterstudyoftheturkishpediatricbonemarrowtransplantationstudygroup
AT ozturkgulyuz prognosticfactorsandanewprognosticindexmodelforchildrenandadolescentswithhodgkinslymphomawhounderwentautologoushematopoieticstemcelltransplantationamulticenterstudyoftheturkishpediatricbonemarrowtransplantationstudygroup
AT ellimurat prognosticfactorsandanewprognosticindexmodelforchildrenandadolescentswithhodgkinslymphomawhounderwentautologoushematopoieticstemcelltransplantationamulticenterstudyoftheturkishpediatricbonemarrowtransplantationstudygroup
AT kayazuhre prognosticfactorsandanewprognosticindexmodelforchildrenandadolescentswithhodgkinslymphomawhounderwentautologoushematopoieticstemcelltransplantationamulticenterstudyoftheturkishpediatricbonemarrowtransplantationstudygroup
AT unalemel prognosticfactorsandanewprognosticindexmodelforchildrenandadolescentswithhodgkinslymphomawhounderwentautologoushematopoieticstemcelltransplantationamulticenterstudyoftheturkishpediatricbonemarrowtransplantationstudygroup
AT hazarvolkan prognosticfactorsandanewprognosticindexmodelforchildrenandadolescentswithhodgkinslymphomawhounderwentautologoushematopoieticstemcelltransplantationamulticenterstudyoftheturkishpediatricbonemarrowtransplantationstudygroup
AT yılmazbengoasebnem prognosticfactorsandanewprognosticindexmodelforchildrenandadolescentswithhodgkinslymphomawhounderwentautologoushematopoieticstemcelltransplantationamulticenterstudyoftheturkishpediatricbonemarrowtransplantationstudygroup
AT karasugulsun prognosticfactorsandanewprognosticindexmodelforchildrenandadolescentswithhodgkinslymphomawhounderwentautologoushematopoieticstemcelltransplantationamulticenterstudyoftheturkishpediatricbonemarrowtransplantationstudygroup
AT ataydidem prognosticfactorsandanewprognosticindexmodelforchildrenandadolescentswithhodgkinslymphomawhounderwentautologoushematopoieticstemcelltransplantationamulticenterstudyoftheturkishpediatricbonemarrowtransplantationstudygroup
AT dagdemirayhan prognosticfactorsandanewprognosticindexmodelforchildrenandadolescentswithhodgkinslymphomawhounderwentautologoushematopoieticstemcelltransplantationamulticenterstudyoftheturkishpediatricbonemarrowtransplantationstudygroup
AT orenhale prognosticfactorsandanewprognosticindexmodelforchildrenandadolescentswithhodgkinslymphomawhounderwentautologoushematopoieticstemcelltransplantationamulticenterstudyoftheturkishpediatricbonemarrowtransplantationstudygroup
AT kocakulker prognosticfactorsandanewprognosticindexmodelforchildrenandadolescentswithhodgkinslymphomawhounderwentautologoushematopoieticstemcelltransplantationamulticenterstudyoftheturkishpediatricbonemarrowtransplantationstudygroup
AT yesilipekmakif prognosticfactorsandanewprognosticindexmodelforchildrenandadolescentswithhodgkinslymphomawhounderwentautologoushematopoieticstemcelltransplantationamulticenterstudyoftheturkishpediatricbonemarrowtransplantationstudygroup